Filing Flows › Comparisons › CDLX vs CEVA
Cardlytics vs Ceva: CDLX and CEVA compared
Cardlytics is the larger company: $32.9M of revenue in its latest quarter (Q3 2026) against $29.0M for Ceva (Q2 2026). Ceva is growing faster (+13% against -30% a year earlier). Ceva is more profitable, with an operating margin of -7.2% against -16.5%.
Where the money goes: CDLX and CEVA
Cardlytics (CDLX) · Q3 2026
Cardlytics, Q3 2026: revenue $32.9M (-30% year over year), operating margin -16.5%, net loss $8.9M, operating cash flow −$5.9M. The chart follows the revenue to costs, profit and cash.
Ceva (CEVA) · Q2 2026
Ceva, Q2 2026: revenue $29.0M (+13% year over year), operating margin -7.2%, net loss $2.9M, operating cash flow $5.8M. The chart follows the revenue to costs, profit and cash.
| Cardlytics (CDLX) | Ceva (CEVA) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $32.9M | $29.0M |
| Revenue growth, Y/Y | -30% | +13% |
| Operating margin | -16.5% | -7.2% |
| Net earnings | −$8.9M | −$2.9M |
| Net margin | -27.2% | -10.0% |
| Operating cash flow | −$5.9M | $5.8M |
| Free cash flow | — | $5.2M |
Where the revenue comes from
Cardlytics
- Engagement based pricing: $21.7M (66%)
- Served based pricing: $10.1M (31%)
- Other Revenue(1): $1.1M (3%)
Ceva
- License: $18.2M (63%)
- Royalty: $10.8M (37%)
Questions
Which is bigger, Cardlytics or Ceva?
Cardlytics is the larger company: $32.9M of revenue in its latest quarter (Q3 2026) against $29.0M for Ceva (Q2 2026).
Is Cardlytics or Ceva growing faster?
Ceva is growing faster (+13% against -30% a year earlier).
Which is more profitable, Cardlytics or Ceva?
Ceva is more profitable, with an operating margin of -7.2% against -16.5%.
More: Cardlytics earnings · how Cardlytics makes money · Ceva earnings · how Ceva makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 10, 2026). Fiscal quarters can end on different dates. Not investment advice.